Profound Medical Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Profound Medical Stock Summary

Profound Medical competes with Si Bone, Sight Sciences, Nevro Corp, Paragon 28, and Pulmonx Corp. Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada. Profound Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 146 people.

Profound Medical Key Financial Ratios

Profound Medical Key Balance Sheet Accounts

Profound Medical Key Income Statement Accounts

Profound Medical Key Cash Accounts

Profound Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Profound Medical's current stock value. Our valuation model uses many indicators to compare Profound Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Profound Medical competition to find correlations between indicators driving Profound Medical's intrinsic value. More Info.Profound Medical Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Profound Medical's Return On Equity is most likely to slightly grow in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Profound Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Profound Medical Corp Systematic Risk

Today, most investors in Profound Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Profound Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Profound Medical growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Profound Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Profound Medical Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Profound Medical Corp based on widely used predictive technical indicators. In general, we focus on analyzing Profound Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Profound Medical's daily price indicators and compare them against related drivers.

When running Profound Medical's price analysis, check to measure Profound Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profound Medical is operating at the current time. Most of Profound Medical's value examination focuses on studying past and present price action to predict the probability of Profound Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profound Medical's price. Additionally, you may evaluate how the addition of Profound Medical to your portfolios can decrease your overall portfolio volatility.